# Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

> **NCT06015269** · PHASE1 · UNKNOWN · sponsor: **Shanghai Cell Therapy Group Co.,Ltd** · enrollment: 200 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** DC cells

## Key facts

- **NCT ID:** NCT06015269
- **Lead sponsor:** Shanghai Cell Therapy Group Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06015269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06015269, "Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06015269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*